Technical analysis of Fulgent Genetics, Inc. (FLGT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally.
Price Performance
| 1 month | +17.13% |
| 3 months | +20.84% |
| Year-to-date | -17.20% |
| 1 year | -1.26% |
| 3 years | -25.20% |
52-Week Range
| 52-week High | $31.04 |
| 52-week Low | $13.46 |
| Avg Volume (90d) | 346K |
Technical Indicators
| SMA 50 | $19.69 |
| SMA 200 | $20.34 |
| Beta | 0.89 |
| 30-day Volatility (annualised) | 28.5% |
| Price vs SMA 50 | +10.5% |
| Price vs SMA 200 | +7.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $22.45 | |
| 2025-11 | $29.58 | +31.8% |
| 2025-12 | $26.27 | -11.2% |
| 2026-01 | $26.20 | -0.3% |
| 2026-02 | $15.33 | -41.5% |
| 2026-03 | $15.90 | +3.7% |
| 2026-04 | $15.19 | -4.5% |
| 2026-05 | $18.14 | +19.4% |
| 2026-06 | $20.52 | +13.1% |
| 2026-07 | $16.55 | -19.3% |
| 2026-08 | $19.37 | +17.0% |
| 2026-09 | $21.75 | +12.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | $0.88 | $2.29B |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.04 | $67M |
Price
| Price | $21.75 |
| Market Cap | $618M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.60 |
| EV / EBITDA | -8.36 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 6.34 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 5.63 |